1721 - 1730 of 9145 Results
Title
Year
- Lack of Asymmetry of Nigrostriatal Dopaminergic Function in Healthy Subjects2020RESTRICTEDTitle: Lack of Asymmetry of Nigrostriatal Dopaminergic Function in Healthy SubjectsJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 6Start Page: 1072End Page: 1076Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28019Citation Count: 23
-
OPENTitle: Item Response Theory Analysis of the MDS‐UPDRS Motor Examination: Tremor vs. Nontremor ItemsJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 9Start Page: 1587End Page: 1595Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28110Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28110Citation Count: 31
-
OPENTitle: An efficient and scalable synthesis of thiazolo ring fused 2-pyridones using flow chemistryJournal Name: ArkivocPublisher: ARKAT USA, Inc.Vol: 2020Issue #: 7Start Page: 365End Page: 378Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.24820/ark.5550190.p011.445Best OA location URL: https://www.arkat-usa.org/get-file/72918/Citation Count: 0
- An Overview of the Active Clinical Trials for Parkinson’s Disease Psychosis2022RESTRICTEDTitle: An Overview of the Active Clinical Trials for Parkinson’s Disease PsychosisJournal Name: Neurodegenerative Disease ManagementPublisher: Informa UK LimitedVol: 12Issue #: 4Start Page: 165End Page: 170Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2217/nmt-2022-0020Citation Count: 0
-
OPENTitle: Opicapone in Uk Clinical Practice: effectiveness, Safety and Cost Analysis in Patients With Parkinson’s DiseaseJournal Name: Neurodegenerative Disease ManagementPublisher: Informa UK LimitedVol: 12Issue #: 2Start Page: 77End Page: 91Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.2217/nmt-2021-0057Best OA location URL: https://eprints.ncl.ac.uk/281877Citation Count: 9
-
OPENTitle: In Silico Studies Comparing the Adjuvant Therapies Approved for Parkinson’s diseaseJournal Name: Journal of Drug Delivery and TherapeuticsPublisher: Society of Pharmaceutical TecnocratsVol: 11Issue #: 3-SStart Page: 104End Page: 110Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.22270/jddt.v11i3-s.4813Best OA location URL: http://jddtonline.info/index.php/jddt/article/download/4813/3895Citation Count: 2
- Triplication of Synaptojanin 1 in Alzheimer’s Disease Pathology in Down Syndrome2022RESTRICTEDTitle: Triplication of Synaptojanin 1 in Alzheimer’s Disease Pathology in Down SyndromeJournal Name: Current Alzheimer ResearchPublisher: Bentham Science Publishers Ltd.Vol: 19Issue #: 12Start Page: 795End Page: 807Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2174/1567205020666221202102832Citation Count: 4
- Predicting Neuropsychiatric Symptoms of Parkinson’s Disease with Measures of Striatal Dopaminergic Deficiency2021RESTRICTEDTitle: Predicting Neuropsychiatric Symptoms of Parkinson’s Disease with Measures of Striatal Dopaminergic DeficiencyJournal Name: Current Alzheimer ResearchPublisher: Bentham Science Publishers Ltd.Vol: 18Issue #: 6Start Page: 499End Page: 504Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2174/1567205018666210827122133Citation Count: 4
- Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and Discovery2021RESTRICTEDTitle: Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and DiscoveryJournal Name: Current Drug Research ReviewsPublisher: Bentham Science Publishers Ltd.Vol: 13Issue #: 2Start Page: 101End Page: 119Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2174/2589977513666210211163711Citation Count: 39
-
RESTRICTEDTitle: Flavaglines: Their Discovery from Plants Used in Traditional Chinese Medicine, Synthesis, and Drug Development Against Cancer and Immune DisordersJournal Name: Current Chinese ChemistryPublisher: Bentham Science Publishers Ltd.Vol: 2Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2174/2666001601666211126091737Best OA location URL: https://hal.science/hal-03806707Citation Count: 0